While our data suggest that IDC‐DCIS cancers may imply a less aggressive phenotype for patients with hormonal receptor or Her2 receptor positive cancers, we do acknowledge that triple negative malignancies may exhibit different biological behavior. This evidence concerns the gene NR4A1 and cancer.